Tethras Technologies, an Irish technology company based at NovaUCD, today announced the launch of a disruptive localisation service to assist mobile App developers with publishing their Apps in multiple languages.
The global Apps industry has experienced massive growth in recent years and is estimated to be worth $4.4 billion by the end of this year. According to Distimo, an App store analytics company, Apple alone had more than 350,000 downloads of paid Apps per day in December 2010.
Application downloads in the Asia-Pacific region are expected to grow to 2.4 billion by 2013. China, Japan and Korea are already strong sources of growth and expansion in these regions is expected to continue. Downloads in Europe are also strong with France, Germany and Spain leading the charge.
Brian Farrell, CEO, Tethras Technologies with the iPad Heart Pro App
The vast majority of Apps are developed in the US and published mainly in English. Tethras, identifying a gap in the market, has developed an innovative cloud-based, localisation as a service (LaaS), to allow App developers easily publish their content in multiple languages. This will enable App developers to access major, non-English speaking growth regions around the World.
Speaking today at NovaUCD, Brian Farrell, CEO, Tethras, said, “Over the past year we have taken a fresh look at the App localisation process. We discovered that the service offered by traditional localisation companies was time consuming, manual and cost prohibitive for the majority of App developers.” He added, “Tethras’ groundbreaking service has stripped away all of the unnecessary layers of the existing process and automated the remaining steps, thereby making App localisation significantly less complicated.”
Tethras has already had significant success with a number of high profile Apps. Most notably, with 3D4Medical’s Heart Pro, a highly-specialised, iPad medical App, which until recently was only available in English. Using Tethras’ service Heart Pro is now a multi-lingual App, also available in Chinese, French, German, Japanese, Korean and Spanish.
The Heart Pro App is currently featured in Apple’s latest iPad TV ad campaign.
According to John Moore, CEO, 3D4Medical, “Within 10 days of releasing Heart Pro in Japanese, Chinese and French we jumped into the Top Ten ranked medical Apps in each of these regions.” He added, “Tethras’ localisation as a service is revolutionary and App localisation is now within easy reach of even the smallest development teams.”
Tethras will be showcasing its new service in the Mobile Apps Showcase at the forthcoming Macworld 2011 Expo. This Showcase will be one of the largest gatherings of mobile App developers under one roof and will feature the latest innovations from iPad, iPhone and iPod touch App developers. The Expo takes place from 27-29 January in the Moscone Center, San Francisco.
ENDS
19 January 2011
For further information contact Micéal Whelan, NovaUCD, e: miceal.whelan@ucd.ie, t: +353 (0)1 716 3712.
Editors Notes
Tethras Technologies Ltd was founded in 2010 by Brian Farrell and Brendan Clavin to provide a complete localisation service specifically for mobile application developers. Tethras’ service localises Apps into all languages supported by iOS and has an extensive network of specialist translators around the world. The company, which currently employs 10 people, is headquartered in NovaUCD, the Innovation and Technology Transfer Centre, and its US headquarters are located in Mountain View, California.
NovaUCD, the Innovation and Technology Transfer Centre, is the hub of knowledge transfer activities at University College Dublin. NovaUCD is responsible for the commercialisation of intellectual property arising from UCD research and for the development of co-operation with industry and business. NovaUCD as a purpose-built centre also nurtures new technology and knowledge-intensive enterprises such as Tethras Technologies. NovaUCD has been funded through a unique public-private partnership that includes AIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers, UCD and Xilinx.